GlassScriptPhysician profile
James H Tabibian
NPI 1831356732
$40,876.28
in general payments reported to CMS, 2019-2025
24 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $2,961 · 2021: $9,504 · 2022: $6,994 · 2023: $16K · 2024: $2,211 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $2,697 · Travel and Lodging: $1,937 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,061.25 |
| Food and Beverage | $2,697.40 |
| Travel and Lodging | $1,937.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $615.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $18,406.85 | 2019-2023 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Evis Exera Lll Colonovideoscope |
| Olympus America INC. | $7,384.75 | 2019-2023 | Disposable Emr Kit, Disposable Grasping Forceps |
| Horizon Therapeutics Plc | $4,050.00 | 2021-2022 | |
| Ipsen Innovation | $3,735.00 | 2022 | |
| Pfizer INC. | $2,127.28 | 2019-2023 | |
| Amgen INC. | $1,800.00 | 2024 | Uplizna |
| Abbvie INC. | $844.03 | 2019-2025 | Skyrizi |
| Conmed Corporation | $517.88 | 2022-2025 | |
| Boston Scientific Corporation | $395.20 | 2019-2025 | General - Biliary Devices |
| Madrigal Pharmaceuticals | $277.59 | 2024-2025 | Rezdiffra, Resmetirom |
| Lucid Diagnostics INC. | $247.84 | 2022-2023 | |
| Ardelyx, INC. | $238.60 | 2024-2025 | Ibsrela |
| Qol Medical, LLC | $202.50 | 2024-2025 | Sucraid, Sucraid |
| Intuitive Surgical, INC. | $109.70 | 2024 | |
| Janssen Biotech, INC. | $107.90 | 2025 | Tremfya |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $97.25 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.51 | 2024-2025 | Xifaxan |
| Ambu INC. | $65.77 | 2022 | |
| Phathom Pharmaceuticals, INC. | $48.68 | 2023-2025 | Voquezna |
| Echosens North America, INC. | $34.94 | 2024 | Fibroscan |
| Braintree Laboratories, INC. | $32.25 | 2024 | Sutab, Suflave |
| Novo Nordisk INC | $27.72 | 2025 | Wegovy |
| Exact Sciences Corporation | $26.31 | 2024 | Cologuard Collection Kit |
| Apollo Endosurgery US INC | $20.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tabibian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.